Applying 'omics technologies in chemicals risk assessment: Report of an ECETOC workshop

Angrish, 2016, Tipping the balance: hepatotoxicity and the 4 apical key events of hepatic steatosis, Toxicol. Sci., 150, 261, 10.1093/toxsci/kfw018

Ankley, 2010, Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment, Env. Toxicol. Chem., 29, 730, 10.1002/etc.34

Becker, 2015, Increasing scientific confidence in adverse outcome pathways: application of tailored Bradford-Hill considerations for evaluating weight of evidence, Regul. Toxicol. Pharmacol., 72, 514, 10.1016/j.yrtph.2015.04.004

Benford, 2010, Application of the Margin of Exposure (MOE) approach to substances in food that are genotoxic and carcinogenic, Food Chem. Toxicol., 48, S2, 10.1016/j.fct.2009.11.003

Bercu, 2010, Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens, Regul. Toxicol. Pharmacol., 58, 369, 10.1016/j.yrtph.2010.08.002

Boobis, 2009, Application of key events analysis to chemical carcinogens and noncarcinogens, Crit. Rev. Food Sci. Nutr., 49, 690, 10.1080/10408390903098673

Brazma, 2001, Minimum information about a microarray experiment (MIAME) - toward standards for microarray data, Nat. Genet., 29, 365, 10.1038/ng1201-365

Bridges, 2017, Framework for the quantitative weight-of-evidence analysis of 'omics data for regulatory purposes, Regul. Toxicol. Pharmacol., 91, S51, 10.1016/j.yrtph.2017.10.010

Conolly, 2017, Quantitative adverse outcome pathways and their application to predictive toxicology, Environ. Sci. Technol., 51, 4661, 10.1021/acs.est.6b06230

ECETOC, 2008

ECETOC, 2010

ECETOC, 2013

ECETOC, 2017

ECHA, 2016, New approach methodologies in regulatory science

EP and Council of the EU, 2008, vol. 353, 1

Fabbri, 2012, Whole genome analysis and microRNAs regulation in HepG2 cells exposed to cadmium, ALTEX, 29, 173, 10.14573/altex.2012.2.173

Farmahin, 2017, Recommended approaches in the application of toxicogenomics to derive points of departure for chemical risk assessment, Arch. Toxicol., 91, 2045, 10.1007/s00204-016-1886-5

Fenner-Crisp, 2016, Key Elements for judging the quality of a risk assessment, Environ. Health Perspect., 124, 1127, 10.1289/ehp.1510483

Gant, 2017, A generic Transcriptomics Reporting Framework (TRF) for omics data processing and analysis, Regul. Toxicol. Pharmacol., 91, S36, 10.1016/j.yrtph.2017.11.001

Jackson, 2014, Case study on the utility of hepatic global gene expression profiling in the risk assessment of the carcinogen furan, Toxicol. Appl. Pharmacol., 274, 63, 10.1016/j.taap.2013.10.019

Judson, 2014, In vitro and modelling approaches to risk assessment from the U.S. Environmental Protection Agency ToxCast programme, Basic Clin. Pharmacol. Toxicol., 115, 69, 10.1111/bcpt.12239

Kauffmann, 2017, Framework for the quality assurance of ‘omics technologies considering GLP requirements, Regul. Toxicol. Pharmacol., 10.1016/j.yrtph.2017.10.007

Langfelder, 2013, When is hub gene selection better than standard meta-analysis?, PLoS One, 8, e61505, 10.1371/journal.pone.0061505

Liu, 2005, Gene expression profiling following in utero exposure to phthalate esters reveals new gene targets in the etiology of testicular dysgenesis, Biol. Reprod., 73, 180, 10.1095/biolreprod.104.039404

MAQC Consortium, 2006, The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements, Nat. Biotechnol., 24, 1151, 10.1038/nbt1239

Meek, 2014, New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis, J. Appl. Toxicol., 34, 1, 10.1002/jat.2949

OECD, 1998

OECD

OECD, 2013

OECD, 2014

OECD, 2015

Oshida, 2015, Identification of chemical modulators of the constitutive activated receptor (CAR) in a gene expression compendium, Nucl. Recept. Signal., 13, e002, 10.1621/nrs.13002

Roth, 2016, A critical review of frameworks used for evaluating reliability and relevance of (eco)toxicity data: perspectives for an integrated eco-human decision-making framework, Environ. Int., 95, 16, 10.1016/j.envint.2016.07.011

Russell, 1959

Sauer, 2017, The challenge of the application of 'omics technologies in chemicals risk assessment: background and outlook, Regul. Toxicol. Pharmacol., 91, S14, 10.1016/j.yrtph.2017.09.020

SEQC/MAQC-III Consortium, 2014, A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium, Nat. Biotechnol., 32, 903, 10.1038/nbt.2957

Sonich-Mullin, 2001, IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis, Regul. Toxicol. Pharmacol., 34, 146, 10.1006/rtph.2001.1493

Thomas, 2013, Temporal concordance between apical and transcriptional points of departure for chemical risk assessment, Toxicol. Sci., 134, 180, 10.1093/toxsci/kft094

Thomas, 2013, Biological networks for predicting chemical hepatocarcinogenicity using gene expression data from treated mice and relevance across human and rat species, PLoS One, 8, e63308, 10.1371/journal.pone.0063308

Tralau, 2015, Regulatory toxicology in the twenty-first century: challenges, perspectives and possible solutions, Arch. Toxicol., 89, 823, 10.1007/s00204-015-1510-0

United Nations, 2015, 10.18356/591dabf9-en

van Ravenzwaay, 2014, The sensitivity of metabolomics versus classical regulatory toxicology from a NOAEL perspective, Toxicol. Lett., 227, 20, 10.1016/j.toxlet.2014.03.004